Font Size: a A A
Keyword [metastatic castration resistant prostate cancer]
Result: 1 - 20 | Page: 1 of 1
1. A Preliminary Clinical Study Of Natural Killer Cell For Treatment Of Metastatic Castration Resistant Prostate Cancer
2. Prognostic Factors For Chemotherapy In Patients With Metastatic Castration Resistant Prostate Cancer
3. Early Evaluation Of The Efficacy And Safety Of Abiraterone Acetate’s Treatment In Metastatic Castration Resistant Prostate Cancer
4. The Research On The Effect Of Serum Surface-enhanced Raman Spectroscopy In Predicting The Sensitivity Of Metastatic Castration-resistant Prostate Cancer To Docetaxel Chemotherapy
5. Analysis Of Prognosis Factors Of Docetaxel In The Treatment Of Metastatic Castration-resistant Prostate Cancer
6. Treatment Of Metastatic Castration-resistant Prostate Cancer With Abiraterone And Docetaxel
7. Clinical Study Of Chinese Medicine CFF-1 Combined With Chemotherapy On Treating Metastatic Castration-Resistant Prostate Cancer
8. Study Following A Steroid Switch From Prednisone To Dexamethasone In Castration-resistant Prostate Cancer Patients Progressing On Abiraterone
9. Epithelial-Mesenchymal Transition Biomarkers In Peripheral Blood Predict Docetaxel Efficacy In Patients With Metastatic Castration-Resistant Prostate Cancer
10. To Explore The Clinical Efficacy Of "Spleen And Dampness And Removing Phlegm Method" Combined With Abiraterone Acetate In The Treatment Of Metastatic Castration-resistant Prostate Cancer Based On The Theory Of "Chuzhuo Peiben"
11. Precise Prognosis Analysis Of Metastatic Castration Resistant Prostate Cancer
12. Analysis Of Factors Related To MCRPC Progression In Patients With High Tumor Burden MHSPC After Endocrine Therapy
13. Analysis Of Predictors Of Initial Resistance To Abiraterone Acetate In Patients With Metastatic Castration-Resistant Prostate Cancer
14. Cross-resistance Between Enzalutamide And Apalutamide Through The AKR1C3/AR-V7 Axis In Advanced Prostate Cancer
15. Preliminary Clinical Application Study Of PSMA-targeted Precision Diagnosis And Treatment In Various Solid Tumor
16. Analysis Of Survival-related Factors In Patients With MCRPC Receiving Abiraterone Treatment
17. Analysis Of The Prognostic Factors Of Docetaxel Combined With Endocrine Therapy For Metastatic Castration-resistant Prostate Cancer
18. The Clinical Efficacy Of Enzalutamide And Abiraterone In The Treatment Of Metastatic Castration-resistant Prostate Cancer
19. Analysis Of Factors Associated With Progression To MCRPC In Patients With Oligo-metastatic Prostate Cancer After Treatment
20. Efficacy Analysis Of Enzalutamide,abiraterone And Bicalutamide In The Treatment Of Metastatic Prostate Cancer
  <<First  <Prev  Next>  Last>>  Jump to